IRIS Accounts Production v25.2.0.378 02640770 Board of Directors 1.4.24 31.3.25 31.3.25 false true false false false true false iso4217:GBP iso4217:USD iso4217:EUR xbrli:shares xbrli:pure utr:tonnes utr:kWh 02640770 2024-03-31 02640770 2025-03-31 02640770 2024-04-01 2025-03-31 02640770 2023-03-31 02640770 2023-04-01 2024-03-31 02640770 2024-03-31 02640770 ns15:EnglandWales 2024-04-01 2025-03-31 02640770 ns14:PoundSterling 2024-04-01 2025-03-31 02640770 ns10:Director1 2024-04-01 2025-03-31 02640770 ns10:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 02640770 ns10:SmallEntities 2024-04-01 2025-03-31 02640770 ns10:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 02640770 ns10:SmallCompaniesRegimeForDirectorsReport 2024-04-01 2025-03-31 02640770 ns10:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 02640770 ns10:FullAccounts 2024-04-01 2025-03-31 02640770 1 2024-04-01 2025-03-31 02640770 ns5:CurrentFinancialInstruments 2025-03-31 02640770 ns5:CurrentFinancialInstruments 2024-03-31 02640770 ns5:Non-currentFinancialInstruments 2025-03-31 02640770 ns5:Non-currentFinancialInstruments 2024-03-31 02640770 ns5:ShareCapital 2025-03-31 02640770 ns5:ShareCapital 2024-03-31 02640770 ns5:RetainedEarningsAccumulatedLosses 2025-03-31 02640770 ns5:RetainedEarningsAccumulatedLosses 2024-03-31 02640770 ns10:RegisteredOffice 2024-04-01 2025-03-31 02640770 ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-04-01 2025-03-31 02640770 ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-03-31 02640770 ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure 2025-03-31 02640770 ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure 2024-03-31 02640770 ns5:LandBuildings 2024-03-31 02640770 ns5:PlantMachinery 2024-03-31 02640770 ns5:FurnitureFittings 2024-03-31 02640770 ns5:LandBuildings 2024-04-01 2025-03-31 02640770 ns5:PlantMachinery 2024-04-01 2025-03-31 02640770 ns5:FurnitureFittings 2024-04-01 2025-03-31 02640770 ns5:LandBuildings 2025-03-31 02640770 ns5:PlantMachinery 2025-03-31 02640770 ns5:FurnitureFittings 2025-03-31 02640770 ns5:LandBuildings 2024-03-31 02640770 ns5:PlantMachinery 2024-03-31 02640770 ns5:FurnitureFittings 2024-03-31 02640770 ns5:MotorVehicles 2024-03-31 02640770 ns5:ComputerEquipment 2024-03-31 02640770 ns5:MotorVehicles 2024-04-01 2025-03-31 02640770 ns5:ComputerEquipment 2024-04-01 2025-03-31 02640770 ns5:MotorVehicles 2025-03-31 02640770 ns5:ComputerEquipment 2025-03-31 02640770 ns5:MotorVehicles 2024-03-31 02640770 ns5:ComputerEquipment 2024-03-31 02640770 ns5:MotorVehicles ns5:LeasedAssetsHeldAsLessee 2024-03-31 02640770 ns5:MotorVehicles ns5:LeasedAssetsHeldAsLessee 2024-04-01 2025-03-31 02640770 ns5:MotorVehicles ns5:LeasedAssetsHeldAsLessee 2025-03-31 02640770 ns5:MotorVehicles ns5:LeasedAssetsHeldAsLessee 2024-03-31 02640770 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2025-03-31 02640770 ns5:WithinOneYear ns5:CurrentFinancialInstruments 2024-03-31 02640770 ns5:Secured 2025-03-31 02640770 ns5:Secured 2024-03-31 02640770 1 ns10:Director1 2024-03-31 02640770 1 ns10:Director1 2023-03-31 02640770 1 ns10:Director1 2024-04-01 2025-03-31 02640770 1 ns10:Director1 2023-04-01 2024-03-31 02640770 1 ns10:Director1 2025-03-31 02640770 1 ns10:Director1 2024-03-31

REGISTERED NUMBER: 02640770 (England and Wales)

| Unaudited Financial Statements |

| for the Year Ended 31 March 2025 |

| for |

| Central Medical Supplies Limited |

Central Medical Supplies Limited (Registered number: 02640770)

Contents of the Financial Statements

for the Year Ended 31 March 2025

Page |

Balance Sheet | 1 |

Notes to the Financial Statements | 2 |

Central Medical Supplies Limited (Registered number: 02640770)

Balance Sheet

31 March 2025

| 2025 | 2024 |

| Notes | £ | £ | £ | £ |

FIXED ASSETS

Intangible assets | 4 | - |  | - |  |

Tangible assets | 5 | 1,123,843 |  | 1,334,167 |  |

1,123,843 |  | 1,334,167 |  |

CURRENT ASSETS

Stocks | 6 | 906,049 |  | 1,099,556 |  |

Debtors | 7 | 4,006,075 |  | 3,519,043 |  |

Cash at bank and in hand | 345,040 |  | 518,565 |  |

5,257,164 |  | 5,137,164 |  |

CREDITORS

Amounts falling due within one year | 8 | 2,715,566 |  | 3,276,143 |  |

NET CURRENT ASSETS | 2,541,598 |  | 1,861,021 |  |

TOTAL ASSETS LESS CURRENT LIABILITIES | 3,665,441 |  | 3,195,188 |  |

CREDITORS

Amounts falling due after more than one year | 9 | (703,985 | ) | (674,785 | ) |

PROVISIONS FOR LIABILITIES | (68,299 | ) | (78,090 | ) |

NET ASSETS | 2,893,157 |  | 2,442,313 |  |

CAPITAL AND RESERVES

Called up share capital | 1,000 |  | 1,000 |  |

Retained earnings | 2,892,157 |  | 2,441,313 |  |

SHAREHOLDERS' FUNDS | 2,893,157 |  | 2,442,313 |  |

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 22 September 2025 and were signed on its behalf by:

Mr P A Champ - Director

Central Medical Supplies Limited (Registered number: 02640770)

Notes to the Financial Statements

for the Year Ended 31 March 2025

1. | STATUTORY INFORMATION

| Central Medical Supplies Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

| Registered number: | 02640770

| Registered office: | CMS House

| Fynney Fields

| Brooklands Way

| Leek

| Staffordshire

| ST13 7QG

| The presentation currency of the financial statements is the Pound Sterling (£).

2. | ACCOUNTING POLICIES

| Basis of preparing the financial statements

| These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

| The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and have been consistently applied within these accounts.

| After making enquiries, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future, being the 12 month period from the date of these accounts being approved, therefore the financial statements have been prepared on a going concern basis.

| Preparation of consolidated financial statements

| The financial statements contain information about Central Medical Supplies Limited as an individual company and do not contain consolidated financial information as the parent of a group. The company is exempt under Section 399(2A) of the Companies Act 2006 from the requirements to prepare consolidated financial statements.

| Significant judgements and estimates

| The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported for revenues and expenses during the year. However, the nature of estimation means that actual outcomes could differ from those estimates.

| The following judgements have been made by the directors in applying the company's accounting policies:

| Turnover

| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

| Revenue is recognised as the company becomes entitled to consideration for the goods supplied.

| Other intangible asset

| The other intangible asset relates to development costs connected with a project undertaken in 2010 and 2011 which is being amortised evenly over 10 years.

| Tangible fixed assets

| Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the term, whichever is shorter.

| Freehold Property |  | - 2% on cost |  |

| Plant and Machinery |  | - Plant and machinery has two methods of depreciation being 25% on reducing balance and 25% on straight line basis. |  |

| Fixtures and fittings |  | - 25% on reducing balance |  |

| Motor Vehicles |  | - 25% on reducing balance |  |

| Computer Equipment |  | - 25% on reducing balance |  |

Central Medical Supplies Limited (Registered number: 02640770)

Notes to the Financial Statements - continued

for the Year Ended 31 March 2025

2. | ACCOUNTING POLICIES - continued

| Stocks

| Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

| Taxation

| Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

| Current or deferred taxation assets and liabilities are not discounted.

| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

| Deferred tax

| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

| Foreign currencies

| Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

| Hire purchase and leasing commitments

| Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

| The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

| Pension costs and other post-retirement benefits

| The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. | EMPLOYEES AND DIRECTORS

| The average number of employees during the year was 26 (2024 - 29 ) .

4. | INTANGIBLE FIXED ASSETS

| Development

| costs

£ |

| COST

| At 1 April 2024

| and 31 March 2025 | 9,389 |  |

| AMORTISATION

| At 1 April 2024

| and 31 March 2025 | 9,389 |  |

| NET BOOK VALUE

| At 31 March 2025 | - |  |

| At 31 March 2024 | - |  |

Central Medical Supplies Limited (Registered number: 02640770)

Notes to the Financial Statements - continued

for the Year Ended 31 March 2025

5. | TANGIBLE FIXED ASSETS

| Fixtures

| Freehold |  | Plant and |  | and

| property |  | machinery |  | fittings

£ | £ | £ |

| COST

| At 1 April 2024 | 1,562,971 |  | 493,698 |  | 2,978 |  |

| Additions | - |  | 2,387 |  | - |  |

| Disposals | (172,956 | ) | (13,120 | ) | - |  |

| At 31 March 2025 | 1,390,015 |  | 482,965 |  | 2,978 |  |

| DEPRECIATION

| At 1 April 2024 | 293,885 |  | 467,177 |  | 1,996 |  |

| Charge for year | 29,529 |  | 21,271 |  | 979 |  |

| Eliminated on disposal | (34,004 | ) | (13,120 | ) | - |  |

| At 31 March 2025 | 289,410 |  | 475,328 |  | 2,975 |  |

| NET BOOK VALUE

| At 31 March 2025 | 1,100,605 |  | 7,637 |  | 3 |  |

| At 31 March 2024 | 1,269,086 |  | 26,521 |  | 982 |  |

| Motor |  | Computer |

| vehicles |  | equipment |  | Totals

£ | £ | £ |

| COST

| At 1 April 2024 | 63,617 |  | 136,755 |  | 2,260,019 |  |

| Additions | 741 |  | 4,185 |  | 7,313 |  |

| Disposals | (30,282 | ) | - |  | (216,358 | ) |

| At 31 March 2025 | 34,076 |  | 140,940 |  | 2,050,974 |  |

| DEPRECIATION

| At 1 April 2024 | 46,935 |  | 115,859 |  | 925,852 |  |

| Charge for year | 6,161 |  | 16,112 |  | 74,052 |  |

| Eliminated on disposal | (25,649 | ) | - |  | (72,773 | ) |

| At 31 March 2025 | 27,447 |  | 131,971 |  | 927,131 |  |

| NET BOOK VALUE

| At 31 March 2025 | 6,629 |  | 8,969 |  | 1,123,843 |  |

| At 31 March 2024 | 16,682 |  | 20,896 |  | 1,334,167 |  |

Central Medical Supplies Limited (Registered number: 02640770)

Notes to the Financial Statements - continued

for the Year Ended 31 March 2025

5. | TANGIBLE FIXED ASSETS - continued

| Fixed assets, included in the above, which are held under hire purchase contracts are as follows:

| Motor

| vehicles

£ |

| COST

| At 1 April 2024 | 31,660 |  |

| Disposals | (17,199 | ) |

| At 31 March 2025 | 14,461 |  |

| DEPRECIATION

| At 1 April 2024 | 20,751 |  |

| Charge for year | 1,985 |  |

| Eliminated on disposal | (12,566 | ) |

| At 31 March 2025 | 10,170 |  |

| NET BOOK VALUE

| At 31 March 2025 | 4,291 |  |

| At 31 March 2024 | 10,909 |  |

6. | STOCKS

2025 | 2024 |

£ | £ |

| Stocks | 906,049 |  | 1,099,556 |  |

7. | DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2025 | 2024 |

£ | £ |

| Trade debtors | 776,645 |  | 1,230,232 |  |

| Amount owed from related party | 940,727 |  | 660,847 |  |

| Other debtors | 532,052 |  | 385,173 |  |

| Directors' current accounts | 1,606,820 |  | 1,171,623 |  |

| Prepayments | 149,831 |  | 71,168 |  |

4,006,075 |  | 3,519,043 |  |

8. | CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |

2025 | 2024 |

£ | £ |

| Bank loans and overdrafts | 138,816 |  | 86,500 |  |

| Hire purchase contracts | 2,745 |  | 4,684 |  |

| Trade creditors | 1,062,082 |  | 1,320,132 |  |

| Taxation and social security | 537,641 |  | 525,343 |  |

| Other creditors | 974,282 |  | 1,339,484 |  |

2,715,566 |  | 3,276,143 |  |

9. | CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR |

2025 | 2024 |

£ | £ |

| Bank loans | 703,985 |  | 672,040 |  |

| Hire purchase contracts | - |  | 2,745 |  |

703,985 |  | 674,785 |  |

Central Medical Supplies Limited (Registered number: 02640770)

Notes to the Financial Statements - continued

for the Year Ended 31 March 2025

9. | CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR - continued

2025 | 2024 |

£ | £ |

| Amounts falling due in more than five years:

| Repayable by instalments

| Bank loans more 5 yr by instal | 417,801 |  | 456,297 |  |

10. | SECURED DEBTS

| The following secured debts are included within creditors:

2025 | 2024 |

£ | £ |

| Bank loans | 842,801 |  | 758,540 |  |

| Hire purchase contracts | 2,745 |  | 7,429 |  |

| RBS Invoice Finance Limited | 596,518 |  | 1,014,847 |  |

1,442,064 |  | 1,780,816 |  |

| The National Westminster Bank PLC holds a fixed and floating charge over all the current and future assets of the company dated 19th December 1992 and 31st May 2016, together with a Legal Mortgage over 4 Fynney Fields, Leekbrook dated 10th May 2013.

| RBS Invoice Finance Limited also hold a fixed and floating charge dated 21st July 2006 over the undertaking and all property and assets present and future including goodwill, book debts, uncalled capital, buildings, fixtures and fixed plant and machinery.

| Hire purchase creditors are secured on the related assets.

11. | FINANCIAL COMMITMENTS

| At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases totalling £219,672 (2024: £113,150).

12. | DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

| The following advances and credits to a director subsisted during the years ended 31 March 2025 and 31 March 2024:

2025 | 2024 |

£ | £ |

| Mr P A Champ

| Balance outstanding at start of year | 1,171,623 |  | 1,082,709 |  |

| Amounts advanced | 435,197 |  | 88,914 |  |

| Amounts repaid | - |  | - |  |

| Amounts written off | - |  | - |  |

| Amounts waived | - |  | - |  |

| Balance outstanding at end of year | 1,606,820 |  | 1,171,623 |  |

| Amounts owed by the director are repayable on demand and interest has been charged at the HMRC approved rates.